As a part of the changing value-based payment model landscape, pay-for-performance programs for medication adherence measures are new for physicians and providers need help understanding the program, explained Mitzi Wasik, PharmD, BCPS.
director of Pharmacy Medicare Programs at Aetna.
PharmD, BCPS,
As a part of the changing value-based payment model landscape, pay-for-performance (P4P) programs for medication adherence measures are new for physicians and providers need help understanding what the program is, explained Mitzi Wasik,
Since providers see such different patient populations and operate in diverse settings, a one-size-fits-all P4P model is no longer the answer.
"Now we're in this new landscape where a patient has to get their bone mineral density test, what happens after that?" Ms Wasik asks. "What medicaiton are they put on? If they have a fall, what happens after the fall? And so we're looking at a more longitudinal type of pay for performance landscape that is now unfolding."
Dr Terrance Mayes and Dr Loretta Erhunmwunsee Discuss Leadership Roles for NCCN Forum on Equity
January 31st 2023Terrance Mayes, EdD, and Loretta Erhunmwunsee, MD, FACS, discuss their new roles as chair and vice-chair, respectively, of the National Comprehensive Cancer Network’s (NCCN) new Diversity, Equity, & Inclusion (DEI) Directors Forum.
Read More
Promoting Health Equity and Resiliency in Trauma-Affected Communities
January 31st 2023On this episode of Managed Care Cast, we speak with Reverend Paul Abernathy, CEO of the Neighborhood Resilience Project and board member of UPMC for You, who discusses his experiences in promoting health and resiliency in trauma-affected communities, as well as challenges related to access and accessibility of care and medical mistrust.
Listen
Examining Telehealth Uptake to Increase Equitable Care Access
January 26th 2023To mark the publication of The American Journal of Managed Care®’s 12th annual health IT issue, on this episode of Managed Care Cast, we speak with Christopher M. Whaley, PhD, health care economist at the RAND Corporation, who focuses on health economics issues, including the influence of the COVID-19 pandemic on health care delivery.
Listen
2 Clarke Drive
Cranbury, NJ 08512